Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Orphan Medicine

LUXEMBOURG - The European Commission should have granted a marketing authorization for Orphacol, an orphan medicinal product from Laboratoires CTRS (Cell Therapies Research & Services) that is used to treat rare and sometimes fatal liver disorders, the General Court ruled.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...